transplanting
expertise
of a team that is available 24/7 from lung offer to transplant.
Lung Bioengineering's centralized EVLP model is designed to help reduce the resource burden throughout the transplant journey.
Helping the best, do their best.
Discover how LBE can elevate your program
- 1
- 2
- 3
- 4
We're mapping a new course for more patients
75% of donor lungs are not used 1 due to concerns about viability, logistical constraints, or complexities in the transplant process.
Lung Bioengineering’s service model minimizes these constraints and complexities by centralizing all the resources you need to navigate the transplant terrain from organ offer to transplant.
The result: a seamless support service for increased organ utilization.
IMPORTANT SAFETY INFORMATION FOR XVIVO PERFUSION SYSTEM (XPSâ„¢) WITH STEEN SOLUTIONâ„¢ PERFUSATE - P180014
Warnings and Precautions
General Warnings
The safety and effectiveness of the XPSâ„¢ System with STEEN Solutionâ„¢ Perfusate device were not evaluated with ideal criteria donor lungs.
Risk for Contamination and Mechanical Trauma
The degree of organ manipulation required for airway and vascular cannulation carries the potential for contamination and mechanical trauma of the donor lungs. Even though not contraindicated, it is not recommended to use an organ with evident signs of mechanical trauma or major contamination.
Please see full Important Safety Information by clicking the button below
Benefits of an LBE partnership
Constant communication. Access to more data.
Our cloud-based, remotely accessible case management software offers immediate data insights and connects transplant physicians with a team of LBE Clinical Specialists and medical consultants, facilitating confident assessment of organ viability.
Minimize costs.
Maximize resources.
At LBE, we only charge for cases that are accepted for transplant.
Our model is centralized so transplant centers can outsource an otherwise cost and resource-intense onsite process.
Simplify the EVLP journey FROM organ offer to transplant.
Our EVLP service model is designed to mitigate the complexities of the process from organ offer to transplant and give transplant centers what they need most: data.
All Resources in one place. From advanced technology to LBE Clinical Specialists.
LBE's dedicated EVLP centers in Silver Spring, MD and Jacksonville, FL house everything needed for an efficient experience. Each facility is powered by advanced EVLP technology, convenient remote case management communication tools for real-time assessment, and a team of EVLP experts available 24/7/365.
[Thanks to] our relationship with Lung Bioengineering we actually saw about 20% increase in our transplant volume.
Dr. Anne W. Brown
Become a LBE partner
contact us
Get started with Lung Bioengineering today. Click below to connect with our staff.
Contact us
visit our centers
Experience firsthand Lung Bioengineering's facilities located in Silver Spring, Maryland, and Jacksonville, Florida.
REIMBURSEMENT SUPPORT
If you have any questions about billing and reimbursement, please see our reimbursement guide.
Reimbursement guide
Onboarding
Our team will guide you throughout your onboarding process, which includes visits to your transplant center.
Support
24/7 support.
365 days a year.
From guided onboarding to continuous support throughout each EVLP case, our team is on hand with the expertise needed to help your center achieve its transplant goals.
Read about LBE's support structures for your centerMaking more lungs available for transplant
Ex vivo lung perfusion (EVLP) can help to increase the availability of donor lungs, which may decrease lung transplant waitlist mortality.
Our EVLP technology facilitates further evaluation of lungs that may not be available for transplant and allows marginal lungs time for reassessment.
This process can help increase the utilization of lungs for transplant.
Ready to start your journey with us?
To learn more about Lung Bioengineering, and how to get started, please fill out the form.
References:
- Reul RM, Loor G, Garcha PS, Goss JA, Rana AA. Allograft discard risk index for lung transplantation. J Heart Lung Transplant. 2021 Dec;40(12):1658-1667. doi: 10.1016/j.healun.2021.08.017. Epub 2021 Sep 9. PMID: 34836606. Back to content